Global Airway/Lung Stent Market Size By Type (Metal, Silicone), By Application (Hospital, Clinic), By Region, And Segment Forecasts, 2023 to 2032

The Global Airway/Lung Stent Market was valued at USD 0.23 billion in 2023 and is projected to reach USD 0.45 billion by 2031, growing at a CAGR of 8.7% during the forecast period from 2023 to 2031. Airway stents play a critical role in the treatment of airway obstructions caused by benign or malignant tumors, tracheobronchial stenosis, and other respiratory disorders. The growing prevalence of respiratory diseases, advancements in stenting technologies, and an aging global population are primary drivers propelling the market. Increasing adoption of minimally invasive procedures further accelerates demand.

Drivers

1. Rising Prevalence of Respiratory Diseases:

Chronic obstructive pulmonary disease (COPD), asthma, and lung cancer are significantly increasing worldwide, leading to a higher demand for airway stenting as a therapeutic intervention to relieve obstructions and improve breathing.

2. Technological Advancements in Stent Design:

Recent innovations, including bioresorbable and drug-eluting stents, are enhancing patient outcomes and reducing complications, thereby fostering greater adoption.

3. Growing Geriatric Population:

Elderly populations are more susceptible to respiratory ailments. The global rise in this demographic group is directly contributing to increased demand for airway/lung stents.

Restraints

1. High Cost of Treatment:

The cost of stent implantation, hospitalization, and follow-up procedures may limit accessibility, particularly in low- and middle-income countries, affecting overall market penetration.

2. Risk of Post-procedural Complications:

Granulation tissue formation, stent migration, and infection remain challenges associated with airway stents, potentially restraining their usage.

Opportunity

1. Expanding Healthcare Access in Emerging Economies:

As countries like India, Brazil, and others strengthen their healthcare infrastructure, access to interventional pulmonary procedures is improving, creating significant market potential.

2. Integration of AI and Imaging for Precision Placement:

Technological integration, such as AI-guided bronchoscopy and real-time imaging, is expected to optimize stent placement and patient outcomes, paving the way for market expansion.

Market by System Type Insights

By system type, the Self-expandable Stents segment accounted for the largest share in 2023. These stents offer advantages such as flexibility, ease of deployment, and adaptability to airway anatomy, making them the preferred choice for treating both benign and malignant airway obstructions.

The Balloon-expandable Stents segment is projected to grow steadily during the forecast period, particularly in complex tracheobronchial strictures where precision placement is vital.

Market by End-use Insights

In 2023, the Hospitals segment emerged as the largest end-use market, accounting for over 50% of revenue share. This is due to the availability of specialized respiratory care units and interventional pulmonologists.

The Ambulatory Surgical Centers (ASCs) segment is expected to witness the highest growth rate, driven by the rising preference for outpatient procedures due to lower costs and shorter recovery times.

Market by Regional Insights

North America dominated the airway/lung stent market in 2023, attributed to the high prevalence of COPD and lung cancer, robust reimbursement frameworks, and widespread adoption of advanced stenting technologies.

Asia-Pacific is projected to exhibit the highest growth rate from 2023 to 2031, owing to the region's expanding healthcare infrastructure, increasing awareness, and the surge in respiratory diseases linked to urban pollution and smoking rates.

Competitive Scenario

Prominent players in the Global Airway/Lung Stent Market include:

Boston Scientific Corporation

Micro-Tech (Nanjing) Co., Ltd.

Taewoong Medical Co., Ltd.

Novatech SA

Merit Medical Systems, Inc.

Cook Medical Inc.

Teleflex Incorporated

Endo-Flex GmbH

These companies are actively pursuing R&D investments, partnerships with hospitals, and geographical expansion strategies to enhance their market presence. For example:

In 2024, Boston Scientific launched a next-gen silicone-covered self-expanding metallic stent with anti-migration properties.

Taewoong Medical announced a strategic collaboration with leading academic centers in the U.S. for developing customized airway stents.

Scope of Work – Global Airway/Lung Stent Market

Report Metric Details

Market Size (2023) USD 0.23 billion

Projected Market Size (2031) USD 0.45 billion

CAGR (2023–2031) 8.7%

Market Segments By System Type (Self-expandable, Balloon-expandable), End-use, Region

Growth Drivers Rise in respiratory diseases, technological advancements, aging population

Opportunities Emerging market expansion, AI integration in bronchoscopy

Key Market Developments

March 2024: Merit Medical Systems introduced a hybrid airway stent combining silicone and nitinol features for improved deployment precision and biocompatibility.

September 2023: Cook Medical received regulatory approval for its covered metallic stent in the EU, expanding its European market reach.

June 2023: Micro-Tech opened a dedicated training center in Singapore to support advanced interventional pulmonology training and drive awareness.

FAQs

1. What is the current market size of the Global Airway/Lung Stent Market?

The market was valued at USD 0.23 billion in 2023.

2. What is the major growth driver of the Global Airway/Lung Stent Market?

The major growth driver is the rising prevalence of respiratory diseases such as COPD and lung cancer.

3. Which is the largest region during the forecast period in the Global Airway/Lung Stent Market?

North America is expected to remain the largest regional market during the forecast period.

4. Which segment accounted for the largest market share in the Global Airway/Lung Stent Market?

The Self-expandable Stents segment accounted for the largest market share in 2023.

5. Who are the key market players in the Global Airway/Lung Stent Market?

Key players include Boston Scientific Corporation, Micro-Tech, Taewoong Medical, Cook Medical, and Merit Medical Systems.